The transcriptional co-activator p300 is a histone acetyltransferase (HAT) that is typically recruited to transcriptional enhancers and regulates gene expression by acetylating chromatin. Here we show that the activation of p300 directly depends on the activation and oligomerization status of transcription factor ligands. Using two model transcription factors, IRF3 and STAT1, we demonstrate that transcription factor dimerization enables the trans-autoacetylation of p300 in a highly conserved and intrinsically disordered autoinhibitory lysine-rich loop, resulting in p300 activation. We describe a crystal structure of p300 in which the autoinhibitory loop invades the active site of a neighbouring HAT domain, revealing a snapshot of a trans-autoacetylation reaction intermediate. Substrate access to the active site involves the rearrangement of an autoinhibitory RING domain. Our data explain how cellular signalling and the activation and dimerization of transcription factors control the activation of p300, and therefore explain why gene transcription is associated with chromatin acetylation.
Signals that emanate from cellular receptors ultimately lead to changes in gene expression that drive cellular change and organismal development. Gene expression is typically controlled through the coordinated activity of DNA-binding transcription factors, chromatin regulators and the general transcription machinery. For instance, in the innate immune system, pattern recognition receptors recognize and engage with various pathogen-associated molecular patterns 1 , and subsequently bind to adaptor proteins such as STING (stimulator of interferon genes). These adaptor proteins engage the latent DNA-binding transcription factor interferon (IFN) regulatory factor 3 (IRF3) and enable recruitment and activation of the non-canonical IκB kinase TBK1 1 . TBK1 then phosphorylates IRF3 in a C-terminal motif, resulting in the removal of autoinhibition, dimerization and adaptor displacement 2, 3 . Activated IRF3 dimers bind to p300/CBP (where CBP is CREB-binding protein; p300 and CBP are also known as KAT3B and KAT3A, respectively) to stimulate chromatin acetylation and gene expression of the antiviral type I IFNs IFNα and IFNβ [3] [4] [5] . Type I IFNs are secreted and bind to specific cell-surface IFN receptors, which results in the activation of Janus kinase-signal transducers and activators of transcription (JAK-STAT) signalling 6 . The activated, tyrosinephosphorylated STATs then dimerize, translocate to the nucleus and bind to p300/CBP to stimulate the transcription of IFN-stimulated genes 7 . p300/CBP are known to interact with more than 400 binding partners including the basal transcription machinery 8 . The large protein interactome of p300/CBP results in near-universal recruitment of these HATs to enhancers, and p300 occupancy has been used to identify enhancers genome-wide 9, 10 . p300/CBP catalyses the acetylation of histone H3K27 to form H3K27ac, a modification that is considered an 'activation' mark 11 . However, recruitment of p300/CBP does not always correlate with gene activation and is occasionally associated with repression [12] [13] [14] [15] [16] . A large number of chromatin regions that bind p300/CBP therefore do not contain this canonical H3K27ac modification, which indicates that HAT activity at such sites is blocked 15, 17 . Therefore, it is a major challenge to understand the mechanism that enables switching between inactive and active states of p300/CBP on enhancers, and to causally link cellular signalling to the recruitment of p300/CBP, the regulation of HAT activity and the establishment of repressed, poised and active chromatin.
Here we have investigated how the activation and oligomerization status of p300 transcription factor ligands such as IRF3 and STAT1 affects the catalytic activity of p300. We found that the kinase-activated and dimeric, but not the inactive or monomeric, variants of these trans cription factors support robust p300 HAT activation. We demonstrate that transcription factor dimerization enables p300 transautoacetylation in a lysine-rich, intrinsically disordered autoinhibitory loop (AIL) in the HAT domain that serves as a 'pseudosubstrate' and is important for regulating the HAT activity of p300 18 . A crystal structure of the core domain of p300 provides a snapshot of a potential trans-autoacetylation reaction intermediate in which the AIL projects into the active site of a neighbouring p300 molecule. As HAT activation is closely linked to transcription factor activation, these results causally relate cellular signalling to the activation and DNA targeting of a chromatin modifier and provide mechanistic insights into the long-standing and general correlation between an active, acetylated chromatin structure and gene transcription.
Transcription factor dimerization activates p300
To explore whether p300 is activated by signal-dependent IRF3 dimerization, we produced three recombinant IRF3 species: inactive monomers (IRF3); active, TBK1-phosphorylated IRF3 dimers (pIRF3); and a truncation mutant that lacked the C-terminal autoinhibitory element (IRF3ΔC) (Extended Data Fig. 1a, b) . Truncation of the C-terminal autoinhibitory element allows for p300/CBP binding but abolishes IRF3 dimerization 19 . We confirmed the oligomerization status by gel filtration chromatography (Extended Data Fig. 1b) , and investigated the effect of IRF3 activation and oligomerization status on the autoacetylation of p300s in the presence of [ 
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(acetyl-CoA). p300s is a short p300 construct that spans from the TAZ1 to the NCBD/IBiD domains and contains a deletion of the flexible Nand C-terminal regions (Extended Data Fig. 4a ). p300s autoacetylated slowly in the absence of IRF3 (Extended Data Fig. 1c ). The inclusion of inactive, monomeric IRF3 or IRF3ΔC did not modify HAT activity (Fig. 1a, Extended Data Fig. 1c ). By contrast, the inclusion of active, TBK1-phosphorylated IRF3 dimers (pIRF3) resulted in a rapid burst of autoacetylation followed by a gradual increase of acetylated p300s (Fig. 1a, b) . As IRF3ΔC did not support p300 HAT activation, IRF3 dimerization and not solely p300 binding is essential for HAT activation. p300 HAT activation was directly dependent on the TBK1-mediated phosphorylation of IRF3 on Ser396, a critical residue for IRF3 activation and dimerization 2, 3 . Only when both TBK1 and IRF3 were included in the reaction did we observe p300 activation (Fig. 1c,  lane 4) . We observed only a modest stimulatory effect of the adaptor protein STING (Fig. 1c, lanes 7-12) , probably owing to the relatively large amounts of TBK1, which is already active and phosphorylates IRF3 even in the absence of STING 20 . We conclude that IRF3 phosphorylation by TBK1 and its dimerization are required for p300 HAT activation.
To analyse the effect of pIRF3 on p300 activation and acetylation of the histone substrate, we established a scintillation proximity HAT assay. We incubated saturating amounts of a biotinylated histone H4 substrate peptide with p300s in the absence or the presence of equimolar pIRF3 and increasing concentrations of [ 3 H]acetyl-CoA (Fig. 1d) . pIRF3 stimulated p300 histone-substrate acetylation, as determined by the increased rate of H4 acetylation obtained in the presence of pIRF3 (V max = 43.8 ± 5.3 cpm min −1 as compared to V max = 22.5 ± 2.8 cpm min −1 in the absence of pIRF3). These data indicate that pIRF3 not only stimulates p300 autoacetylation and activation, but also stimulates more efficient acetylation of the histone substrate.
We also investigated the effect of STAT1 on p300 activation. STATs are activated in response to cytokine receptor engagement and Janus kinase activation 21 . JAK-mediated phosphorylation of STAT1 on Tyr701 induces dimerization and translocation to the nucleus, where STAT1 binds to DNA elements to regulate gene expression. STAT1 contains a C-terminal transactivation domain (TAD) through which it interacts with p300/CBP 7 . A naturally occurring splice variant, STAT1β, lacks the TAD and acts in a dominant negative manner 22 . Structures of the active, STAT1 Tyr701-phosphorylated dimer bound to DNA, as well as the STAT1 TAD bound to the TAZ2 domain of CBP, have been determined previously 23, 24 .
To understand the effect of STAT1 activation and oligomerization status on p300 activity, we produced STAT1ΔN that lacked the N-domain and STAT1ΔΝC lacking the N-domain and the TAD as non-phosphorylated monomers or as Tyr701-phosphorylated dimers (Extended Data Fig. 1e-h ). We found that p300s autoacetylated slowly in the absence of STAT1, and that the addition of non-phosphorylated, monomeric STAT1ΔΝ did not stimulate p300s autoacetylation beyond background levels (Fig. 1e, f) . By contrast, the addition of Tyr701-phosphorylated STAT1ΔN (pSTAT1ΔN) dimers to p300s resulted in a rapid increase of p300 autoacetylation. Activation required the C-terminal TAD of STAT1, as the addition of a Tyr701-phosphorylated STAT1 dimer (pSTAT1ΔNC) that lacked the TAD did not stimulate p300 autoacetylation (Fig. 1e, f) .
STAT1 dimerization, and not solely interaction with the TAZ2 domain, is required for the activation of p300. Unphosphorylated, monomeric STAT1ΔN, which contains the TAD and is able to interact with the TAZ2 domain of CBP, did not stimulate p300 activity. However, stimulation with STAT1 was not as potent compared with that of IRF3, possibly because our STAT1 preparation is unphosphorylated on Ser727, which is required for maximal gene activation 25 . Together, our data are consistent with a model in which the AIL peptide serves as an intramolecular 'pseudosubstrate' and a competitive HAT inhibitor 18 . Dimeric ligands such as pIRF3 and pSTAT1 allow p300 activation by bringing two molecules together to enable trans-autoacetylation of the AIL, which in turn relieves autoinhibition and enables more efficient entry of substrates into the HAT active site.
Structure of p300 adopts an AIL-swap conformation
To further understand the role of the AIL in the regulation of these structural transitions, we crystallized the hypoacetylated form of the catalytic core of p300 comprising the bromo-RING-PHD-HAT domains (BRP-HAT) that contained the AIL. Crystals were obtained using a similar protocol as published previously 26 . Crystals diffracted to a minimal Bragg spacing of 3.1 Å and we determined the structure by molecular replacement (Extended Data Table 1 ). The crystal form contained four p300 molecules in the asymmetric unit (Extended Data  Fig. 2 ). Comparison with our previous structure 26 showed that the bromo-PHD-HAT domains overlay well on each other with a root-meansquare deviation (r.m.s.d.) of approximately 1 Å. However, the RING domains were not visible in the initial electron density map. Anomalous difference density maps showed a density peak for the zinc atom of the RING domain, but it was not at the expected location. Manual repositioning enabled the correct placement of the RING domains into the new position and the refinement of the structure (Fig. 2a, Extended  Data Fig. 3 ).
The p300 molecules show an antiparallel arrangement of the BRP-HAT domains (Extended Data Fig. 2a) . In this configuration, the HAT 
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domains from two neighbouring molecules are closely apposed (Fig. 2a) . In all protomers, AIL residues 1520-1532 adopt a helical extension of α6 which packs against the outwardly rotated RING domain of the neighbouring protomer (Fig. 2a) . In monomer II, residues 1566-1581 extend away from the HAT domain and associate with the substrate-binding pocket of the HAT domain in monomer I, approximately 17 Å away from the lysine substrate binding tunnel (Fig. 2b) . The remainder of the AIL (residues 1532-1564) is disordered. In this conformation, positively charged residues K1568, K1569 and K1570 project towards the highly electronegative substrate-binding pocket of the HAT domain in monomer I (Fig. 2c) . Analysis by size-exclusion chromatography-multi-angle laser-light scattering (SEC-MALS) revealed that p300 is monomeric at low micromolar concentrations (see Extended Data Fig. 6 ), which suggests that the AIL loop-swapped interactions do not appear to mediate the formation of stable dimers, but may instead constitute more transient self-associations. Although the AIL is clearly flexible and the electron density over the exchanged region is not visible in all protomers (Fig. 2b, c , Extended Data Fig. 2b, c) , this arrangement supports the interpretation that, at high concentrations and when in close proximity to each other, two p300 monomers can engage each other through an AIL loop-swap.
Structural rearrangement of the RING domain
We previously proposed that active-site restriction by the RING domain is a negative regulatory mechanism for HAT activity 26 . A restricted active site is predicted to reduce the probability of substrates engaging with the active site by random diffusion, and could thus be important in enabling the regulation of acetylation by substrate recruitment. Consistent with this model, mutations that map to the structural framework that holds the RING domain in place result in HAT activation in cells 26 . In our current structure the RING domain rotates by around 39° away from the HAT active site, which results in an overall displacement by around 22 Å as compared to the previously determined structure that lacks the AIL (Fig. 3a) . The axis of rotation is located perpendicular to the flexible loops L1 and L2 that connect the RING to the PHD domain.
The inward-rotated conformation (magenta in Fig. 3a) is stabilized by interactions between Glu1242 of the RING domain and Arg1645 and Arg1646 of helix α9 of the HAT domain. In addition, Gln1173, Thr1174 and Thr1184 of the RING domain pack against the unusually long loop (L1) in the HAT domain that covers the CoA portion of the Lys-CoA inhibitor. As a result, Leu1182 resides within about 5.5 Å of the lysine moiety of Lys-CoA (Fig. 3b) . This inward conformation of the RING domain thus restricts substrate access to the HAT domain: the incoming AIL from the neighbouring p300 monomer II would clash with the RING domain in the inward conformation (Fig. 3c) .
In the outward-rotated conformation, the interactions that attach the RING domain to the HAT domain are mostly disrupted (Fig. 3b) . Leu1182 is positioned around 15 Å away from the substrate-binding site and the RING domain is cradled by the AIL extension of helix α6 of the neighbouring p300 molecule (monomer II residues 1524-1533; Fig. 3d ). Despite shape complementarity, with a small buried surface area of about 320 Å 2 , the interface is predominantly polar, which is uncharacteristic of a typical protein-protein interface. However, this interaction could help to stabilize an outward-rotated conformation of the RING domain and a more open active site of the HAT, apparently to enable access of the AIL and trans-acetylation.
Regulation of HAT activity by flanking domains
To systematically analyse the flanking domains, we generated a series of p300 constructs (Extended Data Fig. 4a ) and analysed the effect on HAT activity in vitro and in cells. Overexpression of p300 generally resulted in hyperacetylated, active p300 variants (Extended Data  Fig. 4b, c) , which probably masks the functional role of structural elements potentially involved in autoinhibition of deacetylated p300. Deletion of the RING domain did not considerably alter autoacetylation or histone acetylation (Extended Data Fig. 5a ). This deletion did Article reSeArcH not adversely affect the structural integrity of p300, as shown by a crystal structure of the BΔRP module containing this deletion (Extended Data Fig. 5c ). Deletion of the AIL (ΔAIL) in all constructs resulted in decreased histone acetylation, but bromodomain deletion (ΔBd) did not affect HAT function (Extended Data Fig. 5a, b) . Together, our results are consistent with previous observations of CBP that-at least in the active, hyperacetylated state of the enzyme-RING deletion does not substantially affect HAT activity and that the p300 AIL positively contributes to substrate acetylation 27 . We next introduced mutations into full-length p300 and monitored their effect on p300 autoacetylation and p53 acetylation upon transient co-overexpression in cells. Deletion of the RING (ΔR) and CH3 domains resulted in markedly increased p300 autoacetylation and p53 acetylation, but deletion of the bromodomain or AIL had no major effect (Extended Data Fig. 5e ). As expected, introduction of the catalytic mutants D1399Y or Y1467F abolished p300 autoacetylation or p53 acetylation (Extended Data Fig. 5e ). Immunofluorescence analysis showed that wild-type p300 as well as a ΔBd and ΔAIL deletion were uniformly distributed in the nucleus, but that the HAT-activating p300 variants ΔR and ΔCH3 formed nuclear foci that co-localized with p53 (Extended Data Fig. 5d ).
To validate these results, we analysed and confirmed the phenotype of p300 mutants and p53 acetylation in another cell line (Fig. 4a, b ). In addition, we analysed p300 variants in which eleven lysine amino acids (spanning amino acids 1546-1570 of the AIL) were mutated to arginine or glutamate, and found reduced or slightly increased p300 autoacetylation or p53 acetylation levels, respectively (Fig. 4a, b) .
As we observed the formation of nuclear foci only with HATactivating variants, we proposed that hyperacetylation drives p300 to form biomolecular condensates in cells. Accordingly, the introduction of a HAT-inactivating D1399Y mutation into p300 ΔRING, treatment with the p300 HAT inhibitor A-485 28 , or treatment with the p300/ CBP bromodomain inhibitor CBP30 greatly reduced foci formation (Fig. 4c) . We therefore conclude that HAT activation drives biomolecular condensation of p300 in cells, apparently through substrate engagement by the bromodomain.
Regulation of p300 by the AIL and RING domain
We next sought to understand how the highly conserved and intrinsically disordered AIL segment contributes to the regulation of the catalytic function of p300. The AIL spans amino acid residues 1532-1567 and is positively charged in the deacetylated state, with an estimated isoelectric point (pI) of 10.9, and net charge of +7 at neutral pH. By contrast, upon autoacetylation of residues spanning Lys1542-1560 29 , we estimate a pI of 3.5 and a net charge of −2. As the proximal substrate-binding groove of p300 is largely acidic (Fig. 2c) , we proposedconsistent with earlier predictions 30 -that a deacetylated AIL would engage the substrate binding site through electrostatic interactions, presumably to prevent access of positively charged lysine-containing substrates. Given the disordered nature of the AIL, this proposed interaction is expected to be highly dynamic 27 . We tested this hypothesis through all-atom Monte Carlo simulations 31 . To make this approach tractable, our simulations held the backbone dihedral angles associated with the folded domains fixed, but all other degrees of freedom, including all backbone and side chain dihedral angles in the AIL, were fully sampled. As a result, these simulations should be seen to assess how the AIL interacts with the remainder of p300 given the observed crystal structure. Simulations were performed on the AIL in the deacetylated and acetylated states in the context of the p300 monomer. These simulations enabled us to investigate how acetylation influenced the conformation and intramolecular interactions of the AIL.
Simulations of the deacetylated AIL revealed the presence of extensive yet highly degenerate electrostatic interactions between the AIL and the RING domain and between the AIL and the HAT substratebinding site. These interactions were quantifiable in terms of the normalized distances between pairs of amino acid residues (Fig. 5a , Supplementary Video 1). Lysine residues in the AIL dynamically associate through long-range electrostatic interactions with acidic residues (E1334, E1442, E1505, D1622, D1625 and D1628) in the p300 HAT substrate-binding pocket (Fig. 5c ). The importance of these residues for substrate acetylation has been shown previously 32 , and nuclear magnetic resonance data for CBP confirm that the AIL is intrinsically disordered in the deacetylated state 27 . By contrast, in the acetylated state we found no interactions between the AIL and the substrate binding site (Fig. 5b and Supplementary Video 2). The acetylated AIL essentially behaved like a self-avoiding random coil without any strong biases for interaction with itself or with the surrounding folded domains, including the bromodomain. It has been proposed that the AIL of CBP, when acetylated on K1596 (K1558 in p300), engages the bromodomain intramolecularly, thus competing with histone binding and negatively regulating substrate acetylation 27 . Isothermal calorimetry experiments showed the highest binding affinity for multiacetylated peptides, including the diacetylated histone peptides H3(K14ac/K18ac) and H4(K12ac/K16ac), generally following the pattern KacNNNKac (Extended Data Table 2 ). Monoacetylated peptides typically had weaker binding affinity. A crystal structure of the H4(K12ac/K16ac) peptide bound to BΔRP (Extended Data Fig. 5c )
HA-p300 Article reSeArcH confirmed the acetyllysine-specific binding mode. However, a AIL peptide acetylated on the three lysines K1549, K1558 and K1560-corresponding to some of the most highly acetylated residues in the AIL 29 -failed to bind to the BRP module. Thus our interpretation is that the multiacetylated AIL is not a substrate for the bromodomain, presumably because of suboptimal spacing or sequence environment of the acetylated lysine sites of the AIL.
To understand how the RING domain influences the ability of substrates-including the AIL-to enter the active site of an adjacent p300 molecule, we performed simulations of the AIL in the context of the loop-swapped dimer, using a harmonic potential to maintain the AIL in the active site in order to assess potential intermolecular interactions (Fig. 5d, Extended Data Fig. 6a ). In the active RING conformation, the AIL is able to engage the substrate binding site. However, in the inactive conformation, the frequency of contacts between the AIL and the acidic active site residues E1442 and D1444-residues proximal to the lysine substrate binding tunnel-was reduced by 70-75% (Fig. 5d) . Thus, in the inactive conformation, the RING domain at least partially reduces catalytic activity by limiting accessibility of the active site to the AIL and other substrates.
One prediction from our models is that the deacetylated form of p300 adopts a more compact conformation, owing to dynamic engagement of the AIL with the HAT substrate-binding site, whereas the acetylated form adopts a more 'open' conformation (Fig. 5d) . To test this possibility, we produced hypo-and hyperacetylated p300 variants (Extended Data Fig. 6e-g ) and analysed the preparations by SEC-MALLS. All preparations were monomeric at the concentration tested (2 mg ml −1 ) (Extended Data Fig. 6b-d , Extended Data Table 3 ). Hyperacetylation of p300 BRP-HAT resulted in a small decrease in the elution volume, which is indicative of a larger hydrodynamic radius (Extended Data  Fig. 6b) . A similar result was obtained upon comparison of hyper-and hypoacetylated BRP-HAT-CH3 (Extended Data Fig. 6c) . By contrast, a variant that lacks the AIL showed no change in the elution volume upon hyperacetylation (Extended Data Fig. 6c ). Our data are therefore consistent with the model that the catalytic p300 'core' adopts a compact conformation in the hypoacetylated state, with autoacetylation resulting in a more extended conformation.
Discussion
Our findings provide detailed mechanistic insights into how cellular signalling controls the activity of a chromatin regulator. We propose a multi-step process for p300 HAT activation and signal transmission to chromatin (Extended Data Fig. 7a-d) . In the basal state, the deacetylated AIL is expected to maintain an overall positively charged environment in close proximity to the active site of the enzyme, thus preventing access of positively charged lysine-rich substrates. Direct access to the CoA-binding tunnel and autoacetylation of the AIL in cis appears to be prohibited, in part due to the positioning of the RING domain (Fig. 5d) .
Cellular signalling initiates phosphorylation of transcription factors, such as IRF3 or STAT1, which results in their activation and dimerization. The activated, dimeric transcription factors are in their DNA-binding-competent conformation and can engage two molecules of p300 in the nucleus, thus increasing the likelihood of AIL disengagement from its inhibitory position in cis and of its capture in trans by a second p300 molecule. Association of two p300 molecules does not necessarily require precise stereospecific interactions between the structured domains, because acetylation at several lysines in the AIL indicates a series of possible conformations in such transiently associating dimers. We predict that regulated oligomerization uncouples recruitment from HAT activation, which could explain why not all p300/CBP recruitment events result in chromatin acetylation and gene activation [12] [13] [14] [15] [16] [17] 33 . It has been proposed that enhancer RNA interacts with the AIL to regulate CBP HAT activity 34 . We have attempted to reproduce these results using Klf6, one of the most potent enhancer RNAs reported 34 . We could not detect p300 HAT activation using up to equimolar amounts of Klf6 (Extended Data Fig. 7e, g ). We note that, in a previous study, CBP was purified in buffer containing EDTA; this is detrimental to the structure of p300/CBP owing to the presence of multiple zinc-binding domains 35 . When unfolded by incubation with EDTA, CBP and p300 have a high tendency to aggregate and to form non-specific interactions 35 . Paradoxically, as the HAT domain is not affected, inclusion of EDTA can have an 'activating' effect in biochemical assays, apparently due to such non-specific aggregation (Extended Data Fig. 7f) . The detrimental effects of EDTA on the structure and function of p300/CBP need to be taken into account in the interpretation of such data.
The ability of certain histone-modifying enzymes to bind to the post-translational modification (PTM) they generate has led to models in which such enzymes might propagate modified chromatin domains by a positive-feedback loop 36 . According to this view histone PTMs and other chromatin modifications form an additional, Fig. 5 | Acetylation of the AIL regulates dynamic interaction with the substrate-binding pocket of p300. a, Normalized distances between the AIL and residues in the inactive monomer. Inter-residue distances were normalized by the distances expected if the AIL behaved as a selfavoiding random coil. Electrostatic interaction mediated by conserved lysine residues between K1542 and K1560 of the AIL and aspartic acid or glutamic acid residues around the active site of the HAT domain (E1334, E1351, E1442, D1444, E1505, D1622, D1625 and D1628). The extensive contacts between the AIL and the RING domain originate in part from the proximity of the RING domain to the AIL in its inhibitory conformation. b, Normalized distances between the AIL and all residues in the active (acetylated) monomer. After acetylation, lysine-mediated electrostatic interactions are lost. c, Representative conformations with the AIL shown as an ensemble for the inactive deacetylated monomer (left) and the active acetylated monomer (right). The C α atoms of residues in the AIL are coloured according to charge: blue, positive; red, negative; green, noncharged. The HAT substrate-binding groove is more exposed in the active acetylated state, due to both the relative position of the RING domain and the lack of preferential interactions by the AIL. d, Intermolecular interactions in the loop-swapped dimer between the AIL of one HAT and the adjacent subunit of the other. The adjacent subunit is either in the active (top) or inactive (bottom) conformation. In the active state, the AIL is able to directly engage with residues E1442 and E1444 from the adjacent HAT substrate-binding groove, which suggests that certain orientations of the RING domain can sterically hinder access to the AIL.
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DNA-sequence-independent layer of the genome, which is read out by enzymes that recognize these modifications to 'epigenetically' regulate genomic function 36 . An alternative view proposes that histone PTMs ultimately depend on DNA-sequence-dependent recruitment of chromatin modifiers, and so do not necessarily form an independent 'epigenetic' layer of the genome 8, [37] [38] [39] . The controversy has arisen because it has been difficult to disentangle, for most chromatin regulators, the relative contributions of DNA targeting and histone PTM substrate engagement to the overall chromatin-modification reaction.
We show that regulation of p300 is linked to the activation and oligomerization status of transcription factor ligands, and therefore conclude that specificity for p300-mediated chromatin acetylation arises mainly through transcription-factor-mediated and DNAsequence-dependent genome targeting. The next question is how the bromodomain contributes to p300 function. Although it is clear that the bromodomain can engage acetylated histone peptides and bind to hyperacetylated chromatin 26, 40 , deletion or mutation of the bromodomain has no apparent effect on substrate acetylation 26, 41 , has only minimal effects in a haematopoiesis model system 42 , and bromodomain inhibition does not adversely affect genome targeting of CBP 43 . We favour a model in which DNA binding provides the lead anchoring mechanism: local hyperacetylation increases the binding valency by enabling bromodomain substrate engagement, which further helps to compartmentalize the biochemical reaction and contributes to signal maintenance 40 . p300 HAT-activating mutants form biomolecular condensates in cells when transiently overexpressed (Fig. 4c, Extended  Data Fig. 5d ). Treatment with a HAT inhibitor or bromodomain inhibitor greatly reduces the formation of condensates, which indicates that hyperacetylation and bromodomain-substrate engagement are critical in driving assembly. The formation of condensates, possibly through phase-separation, may provide a mechanism to enable signal integration on enhancers and transcriptional control 44 . It will be critical to disentangle cause-effect relationships of DNA targeting, chromatin modification and histone PTM substrate engagement of other chromatin regulators [45] [46] [47] .
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Constructs. For cell-free protein expression, cDNA of p300 (NCBI reference sequence: NM_001429.3) variants were cloned into the pIVEX2.4d vector (Roche) with a N-terminal 6× His tag and a C-terminal Flag tag. In the ΔR constructs, the RING domain encompassing residues 1169-1241 was replaced by a glycine amino acid residue linker. In the ΔAIL constructs, loop amino acid residues comprising residues 1520-1581 were replaced by the flexible linker sequence SGGSG. For Escherichia coli expression, cDNA encoding residues 1048-1282, for the BRP or BΔRP were cloned into the vector pETM-33 (EMBL) with a tobacco etch virus (TEV)-cleavable N-terminal glutathione S-transferase (GST) tag. p300 BRP_HAT variants were cloned into pFASTBAC1 (Thermo Fisher) and expressed in insect cells as shown previously 26 . p300s constructs, spanning amino acid residues 324-2094, were cloned into pFASTBAC1 vector with an N-terminal Flag tag. Haemagglutinin (HA)-tagged full-length p300 variants were cloned into pcDNA3.1 (Thermo Fisher). Point mutations were introduced by QuikChange mutagenesis (Agilent). Point mutations and nucleotide deletions carried out in p300 full-length (1-2414) or p300s (324-2094) were done through transfer vectors as described previously 26 . STAT1ΔN (136-748), STAT1ΔNC (136-713) and IRF3ΔC (1-382) with a C-terminal intein tag were cloned into the pTXB1 vector (New England Biolabs) using the restriction enzymes NdeI (STAT1) or NcoI (IRF3) and SpeI. IRF3 (1-427) with an N-terminal His-tag cleavable by TEV protease was cloned using the restriction enzymes NcoI and XhoI into the vector pETM-11 (EMBL). All constructs were confirmed by DNA sequencing. Expression and purification. Expression and purification of Flag-tagged p300s constructs was done as described previously 2 . This method enables purification of p300s variants that are already pre-acetylated. Expression and purification of p300 BRP_HAT and SIRT2 were performed as described previously 26 . TBK1 was expressed in insect cells and purified as described previously 20 . Cell-free protein synthesis was done in a 50 μl reaction volume. In brief, 10 μg ml −1 of His-p300 variants in pIVEX2.4d were added to a reaction mixture containing 1 mM amino acid mix, 0.8 mM rNTPs (guanosine-, uracil-, and cytidine-5′-triphosphate ribonucleotides), 1.2 mM adenosine-5′-triphosphate, 55 mM HEPES, pH 7.5, 68 μM folinic acid, 0.64 mM cyclic adenosine monophosphate, 3.4 mM dithiothreitol (DTT), 27.5 mM ammonium acetate, 2 mM spermidine, 5 μM ZnCl 2 , 80 mM creatine phosphate, 208 mM potassium glutamate, 16 mM magnesium acetate, 250 μg ml −1 creatine kinase, 27 μg ml −1 T7 RNA polymerase, 0.175 μg ml −1 tRNA and 67 μl ml −1 S30 E. coli bacterial extract. Incubation was carried out at 22 °C with agitation for 16 h. Proteins were purified using Ni-NTA chromatography (IMAC Sepharose 6 FF, GE healthcare) in buffer 1 (20 mM TRIS, pH 8.0, 300 mM NaCl, 1 mM DTT, 5 μM ZnCl 2 ) containing Complete Protease Inhibitors EDTAFree (Roche). The resin was washed with 20 column volumes of buffer 1 and the protein eluted with 5 column volumes of buffer 1 containing 300 mM Imidazole. The protein was concentrated in a pre-washed Amicon Ultra 0.5 ml Ultracel 10K centrifugal filter (molecular weight cut off 10 kDa; EMD Millipore). The protein was buffer-exchanged into buffer 1 using 0.5 ml Zeba Spin desalting columns (molecular weight cut off 7 kDa; Thermo Scientific), flash-frozen in liquid nitrogen and stored at −80 °C.
For expression of GST-BRP and GST-BΔRP fusion proteins in E. coli BL21 (DE3), LB medium enriched with 100 μM ZnCl 2 was used. Cell pellets were resuspended in buffer 1 containing Complete Protease Inhibitors EDTA-Free (Roche) and lysed using a microfluidizer (Microfluidics Corp.). The lysate was clarified by centrifugation for 30 min at 39,000g in a JA-25.5 rotor (Beckman) and applied to a Glutathione Sepharose 4 Fast Flow resin according to instructions from the manufacturer (GE Healthcare). The resin was washed with buffer 1 and incubated with His-tagged TEV protease (1:100 w/w) for 14-16 h at 4 °C. Subtractive Ni-NTA chromatography (IMAC Sepharose 6 FF, GE Healthcare) was then used to remove the residual His-tag and TEV protease. The untagged protein was further purified by gel filtration on a High Load 16/60 Superdex 75 column (GE Healthcare) equilibrated in 20 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP and 5 μM ZnCl 2 . The final protein was concentrated to 15 mg ml −1 in a prewashed Amicon Ultra-15 Centrifugal filter (molecular weight cut off 10 kDa; EMD Millipore), flash-frozen in liquid nitrogen and stored at −80 °C.
The expression and purification of non-phosphorylated STAT1 variants (STAT1ΔN, STAT1ΔNC) and IRF3ΔC (1-382) was done in E. coli using the IMPACT expression system (New England Biolabs). For the expression of Y701 phosphorylated variants (pSTAT1ΔN, pSTAT1ΔNC), proteins were co-expressed with Elk receptor tyrosine kinase domain in E. coli BL21(DE3) TKB1 cells (Agilent). Cells were collected by centrifugation and resuspended in buffer 2 (20 mM HEPES pH 7.5, 500 mM NaCl). The cells were lysed in a microfluidizer (Microfluidics Corp.) and the soluble fraction was obtained by centrifugation for 30 min at 39,000g in a JA-25.5 rotor (Beckman). The supernatant was first passed over chitin beads (New England Biolabs) and washed with buffer 2 for 10 column volumes. The protein was cleaved at 4 °C for 16 h in buffer 2 containing 50 mM DTT, eluted and further purified by gel filtration on a High Load 16/60 Superdex 200 column (GE Healthcare) equilibrated in buffer 2.
GST-STING, comprising the soluble cytoplasmic domain spanning amino acids 138-378, was expressed in E. coli BL21(DE3) at 37 °C for 3 h. ) in presence of 5 mM MgCl 2 and 1 mM ATP. The reaction was incubated at 30 °C for 1 h and then for an additional 10 h at 21 °C. Phosphorylated IRF3 was further purified by sizeexclusion chromatography on a Superdex S200 16/60 column (GE Healthcare) in 20 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP. The production of recombinant histones was done following standard procedures 48 . Crystallization and structure determination. The p300 BRP_HAT construct comprising the AIL and the mutation Y1467F was deacetylated as described previously 26 . The protein at 4.5 mg ml −1 was incubated with a threefold molar excess of the bi-substrate inhibitor Lys-CoA 32 before crystallization. Crystals in the P2 1 space group were grown by hanging-drop vapour diffusion at 4 °C by mixing equal volumes of protein and crystallization solution containing 100 mM HEPES, pH 7.5, 18-22% polyethylene glycol 3350 and 0.2 M NaCl. Crystals were cryoprotected in 20-25% ethylene glycol and drop-frozen in liquid nitrogen. We collected native diffraction data to a minimum Bragg spacing of 3.1 Å resolution at the ESRF on beamline ID29 under a nitrogen gas stream at 100 K, at a wavelength of 1.282 Å. We processed the data with XDS (Extended Data Table 1 ). The structure of the p300 BRP_HAT was determined by molecular replacement using Phaser. There are four copies in the asymmetric unit and the RING domains were initially not visible in the electron density map and are partially disordered. Inspection of an anomalous difference map indicated peak density for the zinc ions and enabled positioning of the RING domain in the outward-rotated conformation. A final model was produced by iterative rounds of manual model building in Coot and refinement using PHENIX. The final model contains residues 1045 -1664 with a deletion of residues 1534-1567 and was refined to a 3.1 Å resolution with an R work and an R free of 19% and 26%, respectively (Extended Data Table 1 ). Analysis of the refined structure by MolProbity showed that there are no residues in disallowed regions of the Ramachandran plot. The MolProbity all-atom-clash score was 1.91, placing the structure in the 100th percentile among structures refined at 3.1 Å resolution (n = 2,108).
The BΔRP construct at 15 mg ml −1 was mixed with 2 mM of a 11-mer histone peptide H4 (10-20) GLGKacGGAKacRHR (only the underlined amino acid sequence is visible in the electron density map) containing two acetylated lysine residues at K12 and K16, H4(K12ac/K16ac). Crystals in the P2 1 2 1 2 1 space group were grown by hanging-drop vapour diffusion at 21 °C by mixing equal volumes of protein and crystallization solution containing 1.6 M ammonium sulfate and 100 mM bicine at pH 9.0. Crystals were cryoprotected in 20% ethylene glycol and drop-frozen in liquid nitrogen. We collected native diffraction data to a minimum Bragg spacing of 2.5 Å resolution at the ESRF on beamline ID29 under a nitrogen gas stream at 100 K, at a wavelength of 1.0 Å (Extended Data Table 1 ). Data processing, molecular replacement and refinement were performed as indicated above. The final model contains two copies of the BΔRP module corresponding to residues 1049-1279 of p300 in the asymmetric unit. As expected, replacement of the RING domain residues 1169-1241 by a single glycine amino acid linker did not adversely affect the remainder of the BP module. Analysis of the refined structure by MolProbity showed that there are no residues in disallowed regions of the Ramachandran plot. The MolProbity all-atom-clash score was 0.97, placing the structure in the 100th percentile (n = 6,960).
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Monte Carlo simulations. All-atom Monte Carlo simulations were performed using ABSINTH implicit solvent model and version 2 of the CAMPARI Monte Carlo simulation engine (http://campari.sourceforge.net) 31 . The initial AIL loop was constructed using MODELLER, and the complete set of backbone and side chain torsional angles were sampled for the AIL for which electron density was missing. Simulation analysis was performed with MDTraj and CTraj (http:// pappulab.wustl.edu/CTraj.html) 49 . The backbone degrees of freedom of the folded domains were not sampled, while all amino acid side chains were fully sampled. CAMPARI simulations explore conformational space through perturbation to the torsional angles (as opposed to Cartesian positions, as is typical for molecular dynamics). Consequently, a fully closed loop represents a major sampling challenge. To address this, we severed the covalent backbone bond between the N-terminal part of the AIL loop and the folded domain, and replaced this bond with a strong harmonic potential that recapitulates the distances constraint associated with the covalent bond. This allows moves to fully rotate the chain and markedly improves the efficiency of conformational sampling.
We generated 5,000 independent non-overlapping starting configurations and used a clustering approach to identify the most distinct 200 conformations. These were used as the starting conformations for full simulations. We ran 200 independent simulations of the deacetylated and acetylated p300 in the monomeric form, and 200 independent simulations of the loop-swapped p300 dimer in the active and inactive form (800 simulations total). Analysis was performed after an initial equilibration. Dimer simulations applied a harmonic potential between residue 1550 from the AIL and residue 1442 from the other monomer to maintain the AIL in the active site. This enabled us to directly compare active-site accessibility of the AIL. For monomer simulations, no restraints were applied.
Each residue on the folded structure was evaluated for contacts with any residue in the AIL, and these contacts were summed to give an effective contact score. In this manner, the residues on the folded structure that most frequently interacted with any residue on the AIL were directly identified. Interaction was primarily electrostatic in nature, with residues E1334, E1444, E1505, D1622, D1625 and D1628 engaging in direct interactions. There are also extensive interactions between the AIL and the RING domain, although we cannot rule out that these interactions are driven by the harmonic potential applied to pull E1442 towards the active site. As might be expected, the AIL-RING interactions differed between the active and inactive conformations.
To assess interactions between the AIL and the folded domains in the monomer simulations, scaling map analysis was performed. In this analysis, a simulation of the AIL as a true self-avoid random coil is performed to generate a reference state, and then the mean inter-residue distances obtained in the full simulations are normalized by the distances obtained from this reference. The self-avoiding random coil simulations are performed using an identical protocol to the full simulations, with the exception that the only contribution to inter-atomic interactions comes from the repulsive part of the Lennard-Jones potential, meaning no attractive interatomic interactions or solvation effects are experienced. This ensures we generate a sequence and structure-specific self-avoiding random coil ensemble that provides a true reference state. Extensive details on the technical aspects associated with the generation of this reference state have been described previously 50 . The scaling maps enable us to easily identify local regions that engage in interactions that cause deviations from self-avoiding random coil behaviour. HAT assays. The standard autoacetylation HAT assay was performed using [ 12) . The gels were analysed by western blotting as indicated below or were fixed for 30 min in a solution containing 3% glycerol, 10% glacial acetic acid, 20% ethanol (v/v/v) in water. The gels were soaked for 5 min in a solution containing 1% glycerol, 5% PEG8000 in water and were dried for 30 min using a Bio-Rad Gel Dryer and the radioactivity quantified on a phosphorimage analyser (Typhoon, GE Healthcare) followed by analysis using ImageJ 1.8.0_112
51
.
A p300 HAT scintillation proximity assay was designed similar to that described previously 28 . In brief, as a substrate we used a synthetic histone H4 peptide containing 15 amino acids derived from the N terminus of human H4 that was chemically attached to biotin with an amino hexanoic linker (Biotin-C6-GRGKGGKGLGKGGAK) (from peptid.de). The synthetic peptide was re-suspended in water and adjusted to pH 7.0 with concentrated NaOH.
A typical reaction contained p300s (50 nM), 12.5 μΜ biotinylated H4 peptide, acetyl-CoA (0.1 μΜ to 10 μΜ set at around 10 For the results shown in Fig. 4 , acetylation reactions were performed in acetylation reaction buffer HAT (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 10% glycerol and 1× complete EDTA-free protease inhibitor (Roche)) with 50 μM acetyl CoA (Sigma), 100 ng ml −1 trichostatin A and 2 μg of purified histone octamer. Reactions were incubated for 30 min at 30 °C and stopped by the addition of 3× SDS gel loading buffer, then used for Coomassie staining and immunoblotting. Multi angle laser light scattering-size exclusion chromatography. Before SEC-MALLS runs, p300 variants were acetylated and deacetylated using p300 HAT or SIRT2 as described previously 26 . The reactions were analysed by liquid chromatography-mass spectrometry as described previously 52 . Size-exclusion chromatography was performed at a flow rate of 0.5 ml min −1 on a Superdex 200 Increase 10/300 GL column equilibrated in SEC-MALLS buffer (20 mM HEPES, 300 mM NaCl, 5 μM ZnCl 2 , 0.5 mM TCEP) at 21 °C. A 50 μl sample of p300 at 2 mg ml −1 was injected onto the column and multi angle laser light scattering was recorded with a laser emitting at 690 nm using a DAWN-EOS detector (Wyatt Technology Corp.). The refractive index was measured using a RI2000 detector (Schambeck SFD). The molecular weight was calculated from differential refractive index measurements across the centre of the elution peaks using the Debye model for protein using ASTRA software version 6.0.5.3. In vitro eRNA transcription. eKlf6 eRNA corresponding to 496 nucleotides of the sense strand of human chr13:5802100-5802596 (ref. 34 ) was produced by in vitro transcription from a pMA plasmid containing a eKlf6 insert synthesized by GeneArt Gene Synthesis (Thermo Fisher). pMA_Klf6 plasmid (50 μg) was linearized with 80 U of KpnI-HF in a final volume of 100 μl and incubated at 37 °C for 14-16 h. The in vitro transcription reaction was done in a final volume of 1 ml, using 1× T7 buffer, T7 RNA Polymerase and 1 U of RNaseOUT Recombinant Ribonuclease Inhibitor (Thermo Fisher). After incubation for 2 h at 37 °C, 0.5 U of TURBO DNase (2 U μl −1 ) (Thermo Fisher) and 1 μM CaCl 2 was added to the reaction and incubated for 30 min at 37 °C. Following DNaseI treatment, 2 μl of a 30 mg ml −1 stock of proteinase K powder (Thermo Fisher), dissolved in proteinase K buffer (10 mM TRIS pH 7.5, 1 mM CaCl 2 and 40% glycerol), was added and incubated for 45 min at 37 °C. Buffer was exchanged into 20 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP using Amicon Ultra-0.5 ml centrifugal filters (molecular weight cut off 3 kDa, EMD Millipore). To further purify the RNA, 3 volumes of TRIzol (Thermo Fisher) was added to the RNA sample, followed by isopropanol precipitation. Purified Kfl6 RNA was resuspended in 20 mM HEPES, pH 7.5, 300 mM NaCl and 0.5mM TCEP. RNA was quantified using a Nanodrop spectrophotometer (Thermo Fisher). The quality of Klf6 was assessed by agarose gel electrophoresis in 1× TBE buffer or using denaturing 6M urea 14% PAGE (Extended Data Fig. 7c) . 
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